We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Biochip Test for CF Mutations in Prenatal Screening

By HospiMedica staff writers
Posted on 30 Apr 2003
A new biochip array for the detection of cystic fibrosis (CF) mutations can be used for multiplex testing, which allows multiple DNA targets to be detected simultaneously in a laboratory setting. More...
The test is the result of a collaboration between Quest Diagnostics (Teterboro, NJ, USA) and Thermo Electron (Waltham, MA, USA).

The test, called CF Portrait, is being used by Quest Diagnostics to perform cystic fibrosis carrier screening, which identifies parents who are at risk of having children with the disease. CF screening is recommended by the American College of Obstetrics and Gynecology and the American College of Medical Genetics for all Caucasian couples contemplating parenthood.

The CF Portrait biochip was designed and is being manufactured by The BioStar unit of Thermo Electron, using the company's Optical ImmunoAssay (OIA) technology to fully automate the detection of nucleic acid hybridization. The biochip is used in conjunction with Quest's DNA extraction and amplification methods. Quest has exclusive rights to incorporate the CF Portrait biochip into its laboratory-testing methods.

"We look forward to expanding our strategic relationship to develop additional genetic targets for biochips beyond cystic fibrosis, and currently have two other multiplex assays under development,” said Marc Casper, president of Thermo's Life and Laboratory Sciences sector.





Related Links:
Quest
Thermo

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.